Idorsia Ltd. (IDRSF)
4.70
0.00 (0.00%)
USD |
OTCM |
Nov 13, 16:00
Idorsia Profit Margin (Quarterly) : -85.62% for Sept. 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -85.62% |
| June 30, 2026 | -202.5% |
| March 31, 2026 | -79.62% |
| December 31, 2025 | -162.1% |
| September 30, 2025 | -206.5% |
| June 30, 2025 | -15.74% |
| March 31, 2025 | |
| December 31, 2024 | -140.2% |
| September 30, 2024 | -385.6% |
| June 30, 2024 | -664.1% |
| March 31, 2024 | |
| December 31, 2023 | -542.3% |
| September 30, 2023 | |
| June 30, 2023 | -645.2% |
| March 31, 2023 | -1.01K% |
| December 31, 2022 | -358.3% |
| September 30, 2022 | -1.03K% |
| June 30, 2022 | -1.30K% |
| Date | Value |
|---|---|
| March 31, 2022 | -3.81K% |
| December 31, 2021 | -5.06K% |
| September 30, 2021 | -843.9% |
| June 30, 2021 | -1.99K% |
| March 31, 2021 | -1.52K% |
| December 31, 2020 | -2.35K% |
| September 30, 2020 | -1.52K% |
| June 30, 2020 | -130.6% |
| March 31, 2020 | -2.39K% |
| December 31, 2019 | -3.43K% |
| September 30, 2019 | -1.83K% |
| June 30, 2019 | -1.92K% |
| March 31, 2019 | -1.63K% |
| December 31, 2018 | -265.2% |
| September 30, 2018 | -1.82K% |
| June 30, 2018 | -1.23K% |
| March 31, 2018 | -1.20K% |
| December 31, 2017 | 42.64% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Basilea Pharmaceutica AG | -- |
| Santhera Pharmaceuticals Holding AG | -- |
| BeOne Medicines Ltd. | 20.36% |
| AC Immune SA | -269.7% |
| CRISPR Therapeutics AG | -879.6% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -61.75% |
| Return on Invested Capital | -199.5% |
| Gross Profit Margin (Quarterly) | 71.69% |
| Operating Margin (Quarterly) | -57.98% |
| Return on Net Operating Assets | -83.11% |